David A. Siegel Becton Dickinson & CO Transaction History

Two Sigma Advisers, LP

$46.1 Billion
Q2 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Becton Dickinson & CO stock. As of the latest transaction made, Two Sigma Advisers, LP holds 271,200 shares of BDX stock, worth $50.2 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

271,200

Previous 41,800 548.8%

Holding current value

$50.2 Million

Previous $9.57 Million 387.93%

% of portfolio

0.1%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$165.15 - $226.42 $37.9 Million - $51.9 Million	229,400 Added 548.8%	271,200 $46.7 Million
Q1 2025 May 15, 2025	SELL	$222.79 - $249.08 $106 Million - $118 Million	-475,100 Reduced 91.91%	41,800 $9.57 Million
Q4 2024 Feb 14, 2025	BUY	$220.02 - $243.75 $12.5 Million - $13.9 Million	57,000 Added 12.39%	516,900 $117 Million
Q3 2024 Nov 14, 2024	BUY	$221.47 - $242.41 $46.8 Million - $51.2 Million	211,100 Added 84.85%	459,900 $111 Million
Q2 2024 Aug 14, 2024	SELL	$225.07 - $246.17 $19.9 Million - $21.8 Million	-88,600 Reduced 26.26%	248,800 $58.1 Million
Q1 2024 May 15, 2024	BUY	$233.45 - $247.73 $44.5 Million - $47.2 Million	190,500 Added 129.68%	337,400 $83.5 Million
Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $34.1 Million - $39.3 Million	146,900 New	146,900 $35.8 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $13.7 Million - $16.1 Million	62,600 New	62,600 $15.9 Million
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $1.22 Million - $1.43 Million	-5,200 Reduced 69.33%	2,300 $567,000
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $1.83 Million - $2.03 Million	7,500 New	7,500 $2 Million
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $4.44 Million - $4.84 Million	-19,300 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$232.72 - $256.47 $4.49 Million - $4.95 Million	19,300 New	19,300 $4.74 Million
Q2 2021 Aug 16, 2021	SELL	$232.65 - $254.58 $119 Million - $130 Million	-510,200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$232.09 - $256.88 $51 Million - $56.4 Million	219,600 Added 75.57%	510,200 $124 Million
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $60.5 Million - $67.1 Million	272,800 Added 1532.58%	290,600 $72.7 Million
Q3 2020 Nov 16, 2020	SELL	$215.77 - $276.76 $72.6 Million - $93.1 Million	-336,275 Reduced 94.97%	17,800 $4.14 Million
Q2 2020 Aug 14, 2020	BUY	$219.9 - $263.41 $71.3 Million - $85.4 Million	324,298 Added 1089.09%	354,075 $84.7 Million
Q1 2020 May 15, 2020	SELL	$195.69 - $279.01 $64.3 Million - $91.7 Million	-328,800 Reduced 91.7%	29,777 $6.84 Million
Q4 2019 Feb 14, 2020	BUY	$236.45 - $266.82 $70 Million - $79 Million	296,200 Added 474.85%	358,577 $97.5 Million
Q3 2019 Nov 14, 2019	SELL	$230.58 - $256.08 $4.52 Million - $5.02 Million	-19,600 Reduced 23.91%	62,377 $15.8 Million
Q2 2019 Aug 14, 2019	BUY	$217.4 - $246.08 $14.5 Million - $16.4 Million	66,709 Added 436.92%	81,977 $20.7 Million
Q1 2019 May 15, 2019	SELL	$206.05 - $248.17 $15.6 Million - $18.8 Million	-75,636 Reduced 83.2%	15,268 $3.81 Million
Q4 2018 Feb 14, 2019	BUY	$204.73 - $257.93 $6.71 Million - $8.46 Million	32,798 Added 56.45%	90,904 $20.5 Million
Q3 2018 Nov 14, 2018	BUY	$233.07 - $256.0 $13.5 Million - $14.9 Million	58,106 New	58,106 $15.2 Million
Q2 2018 Aug 14, 2018	SELL	$208.1 - $233.85 $15.9 Million - $17.9 Million	-76,406 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$205.46 - $240.27 $12.9 Million - $15.1 Million	-62,901 Reduced 45.15%	76,406 $16.6 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $26.3 Million - $31 Million	139,307	139,307 $29.8 Million

Others Institutions Holding BDX

# of Institutions

1,736

Shares Held

259M

Call Options Held

1.82M

Put Options Held

696K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $52.8B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account